跳至主要内容
临床试验/NCT06348095
NCT06348095已完成不适用

Effect of Probiotic WecProB on the Course of Mycoplasma Pneumoniae Pneumonia in Children

Wecare Probiotics Co., Ltd.1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Mycoplasma pneumoniae load

研究概览

简要总结

To evaluate the effectiveness and safety of compound probiotic in shortening the course of illness in children with mycoplasma pneumoniae pneumonia, in comparison with placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
6 Months 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • diagnosis of MPP based on typical clinical manifestations (e.g., fever, cough, abnormal pulmonary auscultation), radiographic evidence of pneumonia on chest imaging, and laboratory findings in accordance with current pediatric community-acquired pneumonia guidelines;
  • MP infection was confirmed in nasopharyngeal secretions and serum samples using PCR and ELISA;
  • age between 6 months and 12 years;
  • disease duration less than 2 weeks;
  • written informed consent provided by the guardians.

排除标准

  • Previous history of wheezing;
  • Cardiovascular disease and congenital tracheal dysplasia;
  • pneumonia induced by other causes;
  • Dysplasia of bronchial and pulmonary tracts;
  • premature infants;
  • Combined with immunosuppressive diseases;
  • Presence of mental illness.

研究组 & 干预措施

Probiotics group

Experimental

10B CFU/ strip/ day WecProB, before meals; Storage: Store in a cool, dry place without sun exposure.

干预措施: Probiotic (Dietary Supplement)

Placebo group

Placebo Comparator

Dextrin, one strip/ day, before meals; Storage: Store in a cool, dry place without sun exposure.

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Mycoplasma pneumoniae load

时间窗: 7 天

Mycoplasma pneumoniae load was detected by tNGS

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验